TKTL2 Antikörper (AA 1-300) (Biotin)
-
- Target Alle TKTL2 Antikörper anzeigen
- TKTL2 (Transketolase-Like 2 (TKTL2))
-
Bindungsspezifität
- AA 1-300
-
Reaktivität
- Human
-
Wirt
- Kaninchen
-
Klonalität
- Polyklonal
-
Konjugat
- Dieser TKTL2 Antikörper ist konjugiert mit Biotin
-
Applikation
- ELISA
- Kreuzreaktivität
- Human
- Aufreinigung
- >95%, Protein G purified
- Immunogen
- Recombinant Human Transketolase-like protein 2 protein (1-300AA)
- Isotyp
- IgG
- Top Product
- Discover our top product TKTL2 Primärantikörper
-
-
- Applikationshinweise
- Optimal working dilution should be determined by the investigator.
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Liquid
- Buffer
-
Preservative: 0.03 % Proclin 300
Constituents: 50 % Glycerol, 0.01M PBS, PH 7.4 - Konservierungsmittel
- ProClin
- Vorsichtsmaßnahmen
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Lagerung
- -20 °C,-80 °C
- Informationen zur Lagerung
- Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
-
- Target
- TKTL2 (Transketolase-Like 2 (TKTL2))
- Andere Bezeichnung
- TKTL2 (TKTL2 Produkte)
- Synonyme
- TKTL2 antikoerper, 4933401I19Rik antikoerper, RGD1304767 antikoerper, transketolase like 2 antikoerper, transketolase-like 2 L homeolog antikoerper, transketolase-like 2 antikoerper, TKTL2 antikoerper, tktl2.L antikoerper, Tktl2 antikoerper
- Hintergrund
-
Background: Plays an essential role in total transketolase activity and cell proliferation in cancer cells, after transfection with anti-TKTL1 siRNA, total transketolase activity dramatically decreases and proliferation was significantly inhibited in cancer cells. Plays a pivotal role in carcinogenesis.
Aliases: TKTL2 antibody, Transketolase-like protein 2 antibody, EC 2.2.1.1 antibody
- UniProt
- Q9H0I9
-